[MDGL] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
09-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 10.79%
YoY- -9.59%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -85,905 -81,197 -70,730 -57,518 -64,549 -63,100 -61,651 24.67%
Tax 1,682 1,502 780 69 -106 0 0 -
NP -87,587 -82,699 -71,510 -57,587 -64,549 -63,100 -61,651 26.29%
Tax Rate - - - - - - - -
Total Cost 87,587 82,699 71,510 57,587 64,549 63,100 61,651 26.29%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -5.08 -4.84 -4.18 -3.37 -3.78 -3.79 -3.72 23.01%
EPS Diluted -5.08 -4.84 -4.18 -3.37 -3.78 -3.79 -3.72 23.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.